Karyopharm Therapeutics Inc.
Most Recent
Karyopharm Therapeutics Gains on FDA Nod for XPOVIO
Yesterday, Karyopharm Therapeutics announced that it had received FDA approval for the first and only nuclear export inhibitor, XPOVIO.